Jim Wilson
President and Founder, Canadian Lyme Disease Foundation
Jim M Wilson, President and Founder of the Canadian Lyme Disease Foundation ( CanLyme – 2003). He has been involved with Lyme Disease including patient advocacy, public awareness, support, research, education (both public and medical), as well as government consultation since 1995. In 2006, he participated in the organization of the Public Health Agency of Canada funded National Lyme Disease Meeting for provincial and federal medical professionals. CanLyme was given ten percent of the seats and provided expert presenters. Since then, he has been invited to meet with provincial Minister’s of Health, engaged in ongoing senior executive level meetings with the Health Canada officials, testified before federal house and senate committees on Lyme Disease and has testified before provincial health committees.
He continues to give many public presentations to various groups relative to Lyme Disease, including employers with large contingents of outdoor workers who are at increasing risk. Mr. Wilson also sits on the Board of the G. Magnotta Foundation for Vector Borne Diseases in Ontario and has been working with scientists on four continents developing a human tissue research program, that will involve using today’s most sophisticated DNA extraction technology and bioinformatics, to study the prevalence of Lyme bacteria in many diseases that share symptomatology with Lyme Disease. This research may also yield better human tests for Lyme and other tick borne diseases. His foundation, CanLyme, has established a Venture Grants research program that is funding Canadian researchers to study various aspects of Lyme Disease.

Jim M Wilson, President and Founder of the Canadian Lyme Disease Foundation ( CanLyme – 2003). He has been involved with Lyme Disease including patient advocacy, public awareness, support, research, education (both public and medical), as well as government consultation since 1995. In 2006, he participated in the organization of the Public Health Agency of Canada funded National Lyme Disease Meeting for provincial and federal medical professionals. CanLyme was given ten percent of the seats and provided expert presenters. Since then, he has been invited to meet with provincial Minister’s of Health, engaged in ongoing senior executive level meetings with the Health Canada officials, testified before federal house and senate committees on Lyme Disease and has testified before provincial health committees.
He continues to give many public presentations to various groups relative to Lyme Disease, including employers with large contingents of outdoor workers who are at increasing risk. Mr. Wilson also sits on the Board of the G. Magnotta Foundation for Vector Borne Diseases in Ontario and has been working with scientists on four continents developing a human tissue research program, that will involve using today’s most sophisticated DNA extraction technology and bioinformatics, to study the prevalence of Lyme bacteria in many diseases that share symptomatology with Lyme Disease. This research may also yield better human tests for Lyme and other tick borne diseases. His foundation, CanLyme, has established a Venture Grants research program that is funding Canadian researchers to study various aspects of Lyme Disease.